InvestorsHub Logo
Followers 4
Posts 479
Boards Moderated 0
Alias Born 01/03/2015

Re: CHM_760 post# 28718

Saturday, 10/12/2019 6:46:09 PM

Saturday, October 12, 2019 6:46:09 PM

Post# of 34625
From Nov 16 2018 article...The U.S. Department of Defense (DoD) has awarded Mayo Clinic researchers $11 million to conduct a Phase 2 trial investigating the TPIV110 vaccine, in combination with Herceptin (trastuzumab), as a therapy for women with HER2-positive breast cancer. The grant was awarded to Keith L. Knutson, PhD, professor of Immunology in the Department of Immunology, and Saranya Chumsri, MD, from the Division of Hematology and Oncology at Mayo Clinic in Jacksonville, Florida.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News